Cargando…
Key Considerations in Targeted Protein Degradation Drug Discovery and Development
Targeting proteins’ enzymatic functions with small molecule inhibitors, as well as functions of receptor proteins with small-molecule agonists and antagonists, were the major forms of small-molecule drug development. These small-molecule modulators are based on a conventional occupancy-driven pharma...
Autores principales: | Qin, Liena, Dai, Han, Wang, Junfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376879/ https://www.ncbi.nlm.nih.gov/pubmed/35978859 http://dx.doi.org/10.3389/fchem.2022.934337 |
Ejemplares similares
-
Editorial: Computational Drug Discovery for Targeting of Protein-Protein Interfaces
por: Meli, Massimiliano, et al.
Publicado: (2021) -
Targeted Protein Internalization and Degradation by
ENDosome TArgeting Chimeras (ENDTACs)
por: Nalawansha, Dhanusha A., et al.
Publicado: (2019) -
Retraction of “Targeted Protein Internalization
and Degradation by ENDosome TArgeting Chimeras (ENDTACs)”
por: Nalawansha, Dhanusha A., et al.
Publicado: (2020) -
Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II
por: Morra, Giulia, et al.
Publicado: (2023) -
Editorial: Protein–Protein Interactions: Drug Discovery for the Future
por: Rapposelli, Simona, et al.
Publicado: (2021)